Annual ROE
253.53%
+605.15%+172.10%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual return on equity is 253.53%, with the most recent change of +605.15% (+172.10%) on December 31, 2023.
- During the last 3 years, MCRB annual ROE has risen by +394.52% (+279.82%).
- MCRB annual ROE is now at all-time high.
Performance
MCRB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
60.75%
-252.81%-80.63%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly return on equity is 60.75%, with the most recent change of -252.81% (-80.63%) on September 30, 2024.
- Over the past year, MCRB quarterly ROE has dropped by -472.94% (-88.62%).
- MCRB quarterly ROE is now -88.62% below its all-time high of 533.69%, reached on December 31, 2023.
Performance
MCRB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MCRB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +172.1% | -88.6% |
| 3 y3 years | +279.8% | +115.3% |
| 5 y5 years | +116.2% | +115.3% |
MCRB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.1% | -88.6% | +103.3% |
| 5 y | 5-year | at high | +172.1% | -88.6% | +102.1% |
| alltime | all time | at high | +116.2% | -88.6% | +102.1% |
Seres Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 60.75%(-80.6%) |
| Jun 2024 | - | 313.56%(-7.9%) |
| Mar 2024 | - | 340.60%(-36.2%) |
| Dec 2023 | 253.53%(-172.1%) | 533.69%(-128.7%) |
| Sep 2023 | - | -1859.43%(+84.6%) |
| Jun 2023 | - | -1007.10%(+2.4%) |
| Mar 2023 | - | -983.96%(+146.9%) |
| Dec 2022 | -351.62%(+721.0%) | -398.48%(+64.9%) |
| Sep 2022 | - | -241.58%(+140.0%) |
| Jun 2022 | - | -100.66%(+46.9%) |
| Mar 2022 | - | -68.52%(+51.9%) |
| Dec 2021 | -42.83%(-69.6%) | -45.12%(+109.0%) |
| Sep 2021 | - | -21.59%(-82.3%) |
| Jun 2021 | - | -122.07%(-11.6%) |
| Mar 2021 | - | -138.04%(-42.0%) |
| Dec 2020 | -140.99%(-196.9%) | -237.98%(-91.7%) |
| Sep 2020 | - | -2867.98%(-2065.7%) |
| Jun 2020 | - | 145.90%(-11.3%) |
| Mar 2020 | - | 164.40%(-1.6%) |
| Dec 2019 | 145.43% | 166.99%(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | 173.24%(-8.0%) |
| Jun 2019 | - | 188.28%(-20.2%) |
| Mar 2019 | - | 235.89%(-51.2%) |
| Dec 2018 | -1563.81%(+1591.3%) | 483.63%(-202.0%) |
| Sep 2018 | - | -474.13%(+139.1%) |
| Jun 2018 | - | -198.33%(+53.6%) |
| Mar 2018 | - | -129.10%(+38.1%) |
| Dec 2017 | -92.46%(+70.7%) | -93.45%(+24.6%) |
| Sep 2017 | - | -74.98%(+0.5%) |
| Jun 2017 | - | -74.58%(+15.7%) |
| Mar 2017 | - | -64.44%(+19.5%) |
| Dec 2016 | -54.18%(+103.1%) | -53.92%(+12.4%) |
| Sep 2016 | - | -47.97%(+15.0%) |
| Jun 2016 | - | -41.73%(+11.7%) |
| Mar 2016 | - | -37.35%(+6.8%) |
| Dec 2015 | -26.67%(-142.7%) | -34.97%(-20.4%) |
| Sep 2015 | - | -43.92%(-23.2%) |
| Jun 2015 | - | -57.21%(-3.6%) |
| Mar 2015 | - | -59.37%(-194.9%) |
| Dec 2014 | 62.53%(+13.9%) | 62.53% |
| Dec 2013 | 54.89% | - |
FAQ
- What is Seres Therapeutics annual return on equity?
- What is the all time high annual ROE for Seres Therapeutics?
- What is Seres Therapeutics annual ROE year-on-year change?
- What is Seres Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Seres Therapeutics?
- What is Seres Therapeutics quarterly ROE year-on-year change?
What is Seres Therapeutics annual return on equity?
The current annual ROE of MCRB is 253.53%
What is the all time high annual ROE for Seres Therapeutics?
Seres Therapeutics all-time high annual return on equity is 253.53%
What is Seres Therapeutics annual ROE year-on-year change?
Over the past year, MCRB annual return on equity has changed by +605.15% (+172.10%)
What is Seres Therapeutics quarterly return on equity?
The current quarterly ROE of MCRB is 60.75%
What is the all time high quarterly ROE for Seres Therapeutics?
Seres Therapeutics all-time high quarterly return on equity is 533.69%
What is Seres Therapeutics quarterly ROE year-on-year change?
Over the past year, MCRB quarterly return on equity has changed by -472.94% (-88.62%)